Latest Strategic Investments News

Janus Electric reported a modest revenue increase in Q1 FY26 despite supply chain setbacks and remains suspended from ASX pending audit completion. A $5 million strategic investment from EVUNI Pte Ltd promises to accelerate growth, particularly in sub-Saharan Africa.

European Lithium Limited reports robust quarterly progress highlighted by significant share sales raising over A$187 million and exceptional rare earth drilling results at its Greenland Tanbreez Project.

Energy Action Ltd reported a 17% revenue increase to $2.89 million in Q1 FY26, driven by strong contract renewals and new business wins, alongside strategic investments in AI-enhanced technology to expand emissions management services.

Vitasora Health Limited reported robust patient program growth and secured new US partnerships, driving revenue above A$1 million for the quarter. A recent A$11 million capital raise positions the company for continued expansion and cash-flow breakeven by late 2026.

Pure Hydrogen Corporation reported strong commercial momentum in the September 2025 quarter, securing multiple hydrogen vehicle orders across Australia and the US, expanding international distribution, and raising fresh capital to fuel growth.

The Star Entertainment Group reported a 5% revenue increase in Q1 FY26 and a halving of its EBITDA loss, while navigating regulatory challenges and advancing a major joint venture exit.

ABx Group Limited reports strong progress in rare earth extraction and clean chemical production, backed by strategic investments and a recent $3 million capital raise.

Carnaby Resources reports strong September quarter progress, including significant high-grade copper-gold drill results, full JV buyout, and a $12.5 million placement to advance its Greater Duchess project.

ASF Group Limited reported a solid cash position of $2.44 million as of September 2025, driven by strategic investment moves and technology development, while extending its share buyback program.

Bubs Australia reported a 30% increase in net revenue to $25.6 million for Q1 FY26, driven by robust US sales and a return to profitability with positive EBITDA. Despite inventory challenges in other regions, the company maintains a solid cash position and anticipates FDA approval by year-end.

PainChek has secured FDA De Novo clearance for its Adult App, opening immediate access to a $175 million AUD US long-term care market and advancing its Infant App commercialization targeting a $15 billion AUD global opportunity.

CAR Group Limited has reported robust FY25 financial results with strong revenue and profit growth, underpinned by strategic investments in AI and digital marketplaces. The company projects continued momentum into FY26, aiming to deepen market leadership across global regions.